For those who have not previously attended, Area Meetings feature light refreshments and a door prize drawing at the conclusion of the meeting for those remaining in attendance
What the FDA Just Announced And Why It Matters The Food and Drug Administration made a significant regulatory move on April 15, 2026: it issued a federal notice confirming that an outside panel of pharmacy advisers will meet this coming July to evaluate seven peptide compounds currently classified under the agency's most restrictive compounding category

Typical dosing progression may include: 0.25 mg once weekly 0.5 mg once weekly 1 mg once weekly 1.7 mg once weekly 2.4 mg once weekly (maintenance dose) Safety Information & Precautions Before using Wegovy, inform your healthcare provider if you have: History of thyroid cancer Multiple endocrine neoplasia syndrome type 2 Pancreatitis history Gallbladder disease Kidney disease Severe gastrointestinal conditions Important safety considerations include: Use under medical supervision Follow the prescribed dosing schedule Do not exceed recommended dosage Monitor for unusual symptoms Higher-dose semaglutide therapy such as Wegovy FlexTouch Pen 1.7 Mg may be used within advanced weight-management treatment plans
This guide covers every shade, every cause, and every warning sign you need to know
A Mounjaro has effects that inhibit gastrointestinal activity, so while it suppresses appetite, gastrointestinal symptoms such as anorexia, nausea, and burping may occur